Miriam Lynn

Dr

  • 288 Citations
  • 8 h-Index
20082019
If you made any changes in Pure these will be visible here soon.

Personal profile

Public Profile

Dr. Miriam Lynn is a molecular biologist with more than 10 years of research experience in the fields of genetics, proteomics and immunology. She completed her PhD in Trinity College Dublin working in the field of parasitology. She continued her studies with a 3 year Post-Doctoral position with the University of British Columbia in Canada focusing on proteomic technologies including mass spectrometry and antibody production.

After this, Miriam Lynn returned to Ireland and took up a position in at the National Children's Research Centre working in paediatric oncology. In May 2011, she took up a position as Experienced Researcher in OncoMark working on a European Framework 7 funded project entitled RATHER which focuses on providing new rationalised therapy options for difficult-to-treat breast cancer subtypes. This position included a secondment as a More Experience Marie Curie Research Fellow at the Cancer Biology and Therapeutics Lab at University College Dublin.

Currently Miriam is working as EMBL Postdoctoral Fellow & Lab. Manager at SAMHRI where she has been working as a member of the Computational and Systems Biology Program, part of the Precision Medicine Theme.

Education/Academic qualification

PhD, Trinity College Dublin, Ireland.

20022008

Bachelor's Degree (Honours), Trinity College Dublin

19982002

External positions

Experienced Researcher, OncoMark Ltd, NovaUCD, Belfield Innovation Park

20112013

Postdoctoral Fellow, Our Lady's Hospital for Sick Children

20102011

Postdoctoral Fellow, University of British Columbia

20072009

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

  • 288 Citations
  • 8 h-Index
  • 10 Article
  • 1 Chapter
  • 1 Review article
3 Citations (Scopus)

Transcriptional and metabolic rewiring of colorectal cancer cells expressing the oncogenic KRASG13D mutation

Charitou, T., Srihari, S., Lynn, M., Jarboui, M. A., Fasterius, E., Moldovan, M., Shirasawa, S., Tsunoda, T., Ueffing, M., Xie, J., Xin, J., Wang, X., Proud, C., Boldt, K., Al-Khalili Szigyarto, C., Kolch, W. & Lynn, D., 2 Jul 2019, In : British Journal of Cancer. 121, 1, p. 37-50 14 p.

Research output: Contribution to journalArticle

Early-life antibiotic-driven dysbiosis leads to dysregulated vaccine immune responses in mice

Lynn, M., Tumes, D., Choo, J., Sribnaia, A., Blake, S., Leong, L., Young, G., Marshall, H., Wesselingh, S., Rogers, G. & Lynn, D., 2018, In : Cell Host & Microbe . 23, p. 1-8

Research output: Contribution to journalArticle

Open Access
File
10 Citations (Scopus)

Investigation of molecular alterations of AKT-3 in triple-negative breast cancer

O'Hurley, G., Daly, E., O'Grady, A., Cummins, R., Quinn, C., Flanagan, L., Pierce, A., Fan, Y., Lynn, M., Rafferty, M., Fitzgerald, D., Pontén, F., Duffy, M. J., Jirström, K., Kay, E. W. & Gallagher, W. M., 2014, In : Histopathology. 64, 5, p. 660-670 11 p.

Research output: Contribution to journalArticle

10 Citations (Scopus)

Study of alveolar rhabdomyosarcoma copy number alterations by single nucleotide polymorphism analysis

Lynn, M., Shah, N., Conroy, J., Ennis, S., Morris, T., Betts, D. & O'Sullivan, M., 1 Jan 2014, In : Applied Immunohistochemistry and Molecular Morphology. 22, 3, p. 213-221 9 p.

Research output: Contribution to journalArticle